Potential mitigating impact of a dipeptidyl peptidase-IV inhibitor, vildagliptin, on oxazolone-induced ulcerative colitis: Targeting the role of PI3K/AKT/mTOR and AMPK/Nrf2 signaling pathways
| Autor: | Awad, Marwa Mahmoud, El-Gohary, Rehab M., Ibrahim, Sarah, Abdel Ghafar, Muhammad Tarek, Farghal, Eman E., Aboalsoud, Alshimaa, El-Shaer, Rehab Ahmed Ahmed |
|---|---|
| Zdroj: | In International Immunopharmacology 30 May 2024 133 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect